Evidence map›Paper›PMID 35862457›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2022

De novo design of protein homodimers containing tunable symmetric protein pockets.

Derrick R Hicks, Madison A Kennedy, Kirsten A Thompson, Michelle DeWitt, Brian Coventry, Alex Kang, Asim K Bera, T J Brunette, Banumathi Sankaran, Barry Stoddard and 1 more

Open access · greenAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
1.5field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Design of High Affinity Binders to Convex Protein Target Sites.bioRxiv : the preprint server for biology · 2024
    Article
  9. Article
  10. Article
  11. Research square · 2023
    Article
  12. Article
  13. Article
  14. Article
  15. De novo design of protein homodimers containing tunable symmetric protein pockets.Proceedings of the National Academy of Sciences of the United States of America · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 1 country.

Derrick R HicksDepartment of Biochemistry, University of Washington, Seattle, WA 98195.ORCID 0000-0003-2950-1848
Madison A KennedyDepartment of Biochemistry, University of Washington, Seattle, WA 98195.ORCID 0000-0003-3422-9172
Kirsten A ThompsonDepartment of Biochemistry, University of Washington, Seattle, WA 98195.ORCID 0000-0001-9388-9539
Michelle DeWittDepartment of Biochemistry, University of Washington, Seattle, WA 98195.
Brian CoventryDepartment of Biochemistry, University of Washington, Seattle, WA 98195.
Alex KangDepartment of Biochemistry, University of Washington, Seattle, WA 98195.
Asim K BeraDepartment of Biochemistry, University of Washington, Seattle, WA 98195.ORCID 0000-0001-9473-2912
T J BrunetteDepartment of Biochemistry, University of Washington, Seattle, WA 98195.ORCID 0000-0003-0748-8224
Banumathi SankaranMolecular Biophysics and Integrated Bioimaging, Berkeley Center for Structural Biology, Lawrence Berkeley National Laboratory, Berkeley, CA 94720.
Barry StoddardDivision of Basic Sciences, Fred Hutchinson Cancer Research Center, Seattle, WA 98109.
David BakerDepartment of Biochemistry, University of Washington, Seattle, WA 98195.ORCID 0000-0001-7896-6217
University of Washington · USHoward Hughes Medical Institute · USFred Hutch Cancer Center · USLawrence Berkeley National Laboratory · US

Funding

User Training and OutreachP30GM124169 · NIGMS · UNIVERSITY OF CALIF-LAWRENC BERKELEY LAB · PI PAUL David ADAMS, Gregory L Hura · 2017 to 2026
$28.6M
Project 4: Novel reagent development to enable molecular characterizationU19AG065156 · NIA · UNIVERSITY OF WASHINGTON · PI MACCOSS, MICHAEL · 2020 to 2024
$15.9M
MINOS (Macromolecular Insights on Nucleic acids Optimized by Scattering)R01GM105404 · NIGMS · UNIVERSITY OF CALIF-LAWRENC BERKELEY LAB · PI TAINER, JOHN A. · 2012 to 2015
$2.1M
Determination of the basis of ligand binding via engineering and crystallographyR01GM115545 · NIGMS · FRED HUTCHINSON CANCER RESEARCH CENTER · PI STODDARD, BARRY L. · 2015 to 2018
$1.4M
Combined computational and structural studies to create novel macromolecular recognition propertiesR01GM139752 · NIGMS · FRED HUTCHINSON CANCER RESEARCH CENTER · PI STODDARD, BARRY L. · 2021 to 2023
$1.1M
Howard Hughes Medical InstituteNIA NIH HHS U19 AG065156NIGMS NIH HHS P30 GM124169NIGMS NIH HHS R01 GM105404NIGMS NIH HHS R01 GM115545NIGMS NIH HHS R01 GM139752
6 · The paper itself

Abstract

Function follows form in biology, and the binding of small molecules requires proteins with pockets that match the shape of the ligand. For design of binding to symmetric ligands, protein homo-oligomers with matching symmetry are advantageous as each protein subunit can make identical interactions with the ligand. Here, we describe a general approach to designing hyperstable C2 symmetric proteins with pockets of diverse size and shape. We first designed repeat proteins that sample a continuum of curvatures but have low helical rise, then docked these into C2 symmetric homodimers to generate an extensive range of C2 symmetric cavities. We used this approach to design thousands of C2 symmetric homodimers, and characterized 101 of them experimentally. Of these, the geometry of 31 were confirmed by small angle X-ray scattering and 2 were shown by crystallographic analyses to be in close agreement with the computational design models. These scaffolds provide a rich set of starting points for binding a wide range of C2 symmetric compounds.

Indexed as

LigandsProtein SubunitsModels, MolecularProtein BindingLigandsProtein Subunitshomodimerprotein designrepeat proteinscaffoldsymmetry

Identifiers

PMID35862457
PMCPMC9335249
OpenAlexW4286499342

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.